학술논문
LONGER-TERM CONCIZUMAB PROPHYLAXIS IN PATIENTS WITH HAEMOPHILIA A OR B WITH INHIBITORS: ≥1-YEAR (56-WEEK CUT-OFF) EFFICACY AND SAFETY RESULTS FROM THE PHASE 3 EXPLORER7 TRIAL
Document Type
ConferencePaper
Author
Source
HAEMOPHILIA. 29:99-99
Subject
Language
English
English
English
ISSN
1351-8216